FDA slows synthetic-dye phase-out as 160 food and ag groups push to renew USMCA

Two regulatory developments are reshaping near-term strategy for food and agriculture companies in the United States. The FDA revised the timeline for phasing out synthetic food dyes, with the process reportedly slowing as of June 15, according to DLA Piper. Separately, nearly 160 food and agriculture organizations signed a coordinated letter calling on policymakers to renew the United States-Mexico-Canada Agreement ahead of its July 1 review date.

FDA's synthetic-dye timeline shifts

The FDA's effort to phase out synthetic food colorants — a process that had been building momentum — has decelerated, based on DLA Piper's June 15 analysis. For manufacturers that depend on artificial dyes for product consistency and shelf appeal, the revised pace offers more runway but also prolongs regulatory uncertainty. Companies that had already begun reformulating toward natural alternatives now face a recalibrated competitive environment.

Synthetic dyes have faced intensifying scrutiny from health advocates and some state legislatures, making the federal timeline a closely watched variable across the packaged food sector. A slower federal phase-out does not eliminate pressure from state-level measures, which have moved independently of FDA action. Manufacturers operating across multiple states will need to track both tracks simultaneously.

Industry rallies around USMCA renewal

Nearly 160 food and agriculture organizations signed a joint letter urging the renewal of USMCA ahead of the agreement's July 1 review, according to DLA Piper. The breadth of that coalition — spanning producers, processors, and trade associations — signals how central the agreement has become to cross-border supply chains in North America. Any modification to USMCA terms could affect tariff structures, market access, and the flow of agricultural inputs across the U.S., Mexico, and Canada.

The July 1 review is a formal mechanism built into the agreement that allows the parties to assess and potentially renegotiate provisions. Industry groups signing the letter appear to be signaling a preference for stability over renegotiation, particularly amid existing cost pressures throughout food supply chains. The coordinated effort reflects how seriously the sector views any disruption to the trade framework that underpins North American food commerce.

Protein and functional claims keep expanding

Beyond the regulatory headlines, DLA Piper's June 15 reporting notes that protein and functional claims continue to proliferate across food and beverage categories. Brands are increasingly positioning products around specific nutritional attributes to differentiate in crowded retail environments. This trend places added compliance responsibility on manufacturers, who must substantiate claims against FDA labeling standards.

The expansion of functional claims also intersects with the dye and ingredient scrutiny narrative: consumers and retailers demanding cleaner labels are simultaneously demanding more defined health benefits. Companies navigating both pressures must balance formulation, cost, and regulatory defensibility at once. For food-industry professionals, the convergence of these forces makes proactive regulatory counsel and supply-chain flexibility increasingly essential operating requirements.